Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06441474
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-05-22
Brief Title:
Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women
Sponsor:
University of Colorado Denver
Organization:
University of Colorado Denver
Study Overview
Official Title:
Understanding and Addressing Rejection of Personalized Cancer Risk Information
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The Understanding and Addressing Rejection of Personalized Cancer Risk Information study is a longitudinal observational study conducted to understand the nature of phenomenon of personalized cancer risk rejection in the context of mammography screening
Detailed Description:
The Understanding and Addressing Rejection of Personalized Cancer Risk Information study seeks to understand the nature of the phenomenon of personalized cancer risk rejection in the context of mammography screening by 1 identifying demographic and psychological factors associated with risk rejection and 2 identify how risk rejection influences risk-concordant mammography seeking behavior The study will test a priori theory-derived hypotheses about the precursors of risk rejection and the influence of rejection on real-life screening decision making
The Breast Cancer Risk Assessment Tool BCRAT will be used to asses participants breast cancer risk This model is designed to estimate breast cancer risk in women 35-84 and uses the following predictors 1 age 2 age at first menstrual period 3 age at first live birth 4 first-degree relatives with breast cancer 5 previous breast biopsy with atypical hyperplasia and 6 raceethnicity Participants will be required to complete the baseline survey in which they receive their Gail model risk estimate and respond to that risk estimate They will then complete a 12-month follow-up survey
The Breast Cancer Risk Assessment Tool BCRAT will be used to asses participants breast cancer risk This model is designed to estimate breast cancer risk in women 35-84 and uses the following predictors 1 age 2 age at first menstrual period 3 age at first live birth 4 first-degree relatives with breast cancer 5 previous breast biopsy with atypical hyperplasia and 6 raceethnicity Participants will be required to complete the baseline survey in which they receive their Gail model risk estimate and respond to that risk estimate They will then complete a 12-month follow-up survey
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1R01CA279953-01 | NIH | None | httpsreporternihgovquickSearch1R01CA279953-01 |